Analgesics in Belgium in 2026 is displaying a plateau in growth as current value sales stabilise, contrasting with some neighbouring countries, where demand continues to recover or expand. This subdued performance is a direct result of proactive government health campaigns and revised clinical guidance, which now favour multimodal approaches to pain management and discourage unnecessary or long-term use of painkillers. The environment is characterised by strong consumer loyalty to established brands, particularly those endorsed by pharmacists, but competitive pressure from value-focused retailers and heightened price sensitivity are constraining manufacturers' ability to drive value through pricing strategies. Meanwhile, innovation is reshaping the landscape, with rising demand for natural and non-medicated options, especially among consumers seeking alternatives for muscle and joint pain. To remain competitive, companies must focus on product differentiation, cost efficiency, and the expansion of digital and e-commerce channels, while aligning their portfolios with prevention-oriented and holistic pain relief trends.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Belgium report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Belgium?
- Which are the leading brands in Analgesics in Belgium?
- How are products distributed in Analgesics in Belgium?
- How has the regulatory and operating environment for Analgesics changed in Belgium?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Stagnation as economic and demographic factors and government guidance limit growth
Healthcare guidance shifts chronic pain management away from systemic painkillers
Natural and topical alternatives gain ground amid shifting consumer preferences
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Healthcare professionals expected to promote multimodal pain relief, reducing long-term analgesics use
Non-medicated and natural solutions will attract price-conscious consumers seeking alternatives
Value-oriented retailers to intensify the price competition and challenge premium positioning
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
UPSA Médica leverages brand trust to reinforce leadership
Demand for natural topical pain relief impacts the competition and provides opportunities
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies anchors leadership through professional trust and brand equity
Retail e-commerce expands as natural and alternative brands find digital traction
Chart 1 Retail Channels 2021-2026
Natural ingredients and novel formats steer product development
Recent launches showcase format diversification and brand extension
Competitive dynamics reward innovation and channel agility
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!